Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Appendix
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Das, S. K.
Right arrow Articles by Elbein, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Das, S. K.
Right arrow Articles by Elbein, S. C.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 53:3300-3306, 2004
© 2004 by the American Diabetes Association, Inc.

Calsquestrin 1 (CASQ1) Gene Polymorphisms Under Chromosome 1q21 Linkage Peak Are Associated With Type 2 Diabetes in Northern European Caucasians

Swapan Kumar Das1, Winston Chu1, Zhengxian Zhang1, Sandra J. Hasstedt2, and Steven C. Elbein1,3

1 Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas
2 Department of Human Genetics, University of Utah Health Sciences Center, Salt Lake City, Utah
3 Department of Endocrinology, Central Arkanasas Veterans Healthcare System, Little Rock, Arkansas

Genome-wide scans in multiple populations have identified chromosome 1q21-q24 as one susceptibility region for type 2 diabetes. To map the susceptibility genes, we first placed a dense single nucleotide polymorphism (SNP) map across the linked region. We identified two SNPs that showed strong associations, and both mapped to within intron 2 of the calsequestrin 1 (CASQ1) gene. We tested the hypothesis that sequence variation in or near CASQ1 contributed to type 2 diabetes susceptibility in Northern European Caucasians by identifying additional SNPs from the public database and by screening the CASQ1 gene for additional variation. In addition to 15 known SNPs in this region, we found 8 new SNPs, 3 of which were in exons. A single rare nonsynonymous SNP in exon 11 (A348V) was not associated with type 2 diabetes. The associated SNPs were localized to the region between –1,404 in the 5' flanking region and 2,949 in intron 2 (P = 0.002 to P = 0.034). No SNP 3' to intron 2, including the adjacent gene PEA15, showed an association. The strongest associations were restricted to individuals of Northern European ancestry ascertained in Utah. A six-marker haplotype was also associated with type 2 diabetes (P = 0.008), but neither transmission disequilibrium test nor family-based association studies were significant for the most strongly associated SNP in intron 2 (SNP CASQ2312). An independent association of SNPs in introns 2 and 4 with type 2 diabetes is reported in Amish families with linkage to chromosome 1q21-q24. Our findings suggest that noncoding SNPs in CASQ1 alter diabetes susceptibility, either by a direct effect on CASQ1 gene expression or perhaps by regulating a nearby gene such as PEA15.

Address correspondence and reprint requests to Steven C. Elbein, MD, Professor of Medicine, University of Arkansas for Medical Sciences, Endocrinology 111J-1/LR, John L. McClellan Memorial Veterans Hospital, 4700 W. 7th St., Little Rock, AR 72205. E-mail: elbeinstevenc{at}uams.edu


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
M. Fu, M. M. Sabra, C. Damcott, T. I. Pollin, L. Ma, S. Ott, J. C. Shelton, X. Shi, L. Reinhart, J. O'Connell, et al.
Evidence That Rho Guanine Nucleotide Exchange Factor 11 (ARHGEF11) on 1q21 is a Type 2 Diabetes Susceptibility Gene in the Old Order Amish
Diabetes, May 1, 2007; 56(5): 1363 - 1368.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
W. S. Chu, S. K. Das, H. Wang, J. C. Chan, P. Deloukas, P. Froguel, L. J. Baier, W. Jia, M. I. McCarthy, M. C.Y. Ng, et al.
Activating Transcription Factor 6 (ATF6) Sequence Polymorphisms in Type 2 Diabetes and Pre-Diabetic Traits
Diabetes, March 1, 2007; 56(3): 856 - 862.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. K. Das, W. S. Chu, T. C. Hale, X. Wang, R. L. Craig, H. Wang, A. R. Shuldiner, P. Froguel, P. Deloukas, M. I. McCarthy, et al.
Polymorphisms in the Glucokinase-Associated, Dual-Specificity Phosphatase 12 (DUSP12) Gene Under Chromosome 1q21 Linkage Peak Are Associated With Type 2 Diabetes
Diabetes, September 1, 2006; 55(9): 2631 - 2639.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Fu, C. M. Damcott, M. Sabra, T. I. Pollin, S. H. Ott, J. Wang, M. J. Garant, J. R. O'Connell, B. D. Mitchell, and A. R. Shuldiner
Polymorphism in the Calsequestrin 1 (CASQ1) Gene on Chromosome 1q21 Is Associated With Type 2 Diabetes in the Old Order Amish
Diabetes, December 1, 2004; 53(12): 3292 - 3299.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2004 by the American Diabetes Association.